Estimated lifetime drug use, impulsivity, and psychopathology in recreational ecstasy users

References

• Advisory Council on the Misuse of Drugs (2009). MDMA (‘ecstasy’): A review of its harms and classification under the Misuse of Drugs Act 1971. London: Home Office.
   Google Scholar
• Allen, R. P., McCann, U. D., & Ricuarte, G. A. (1993). Persistent effects of (+/−) 3,4-methylene- dioxymethamphetamine (MDMA, ‘Ecstasy’) on human sleep. Sleep, 16, 560–564.
   PubMed Web of Science ®Google Scholar
• Barratt, E.S. (1994). Impulsivity: Integrating cognitive, behavioural, biological and environmental data. In: W. B. McCown, J. L. Johnson, & M. B. Shure ( eds) The impulsive client: Theory, research and treatment (pp. 39–56). Washington: APA.
   Google Scholar
• Bolla, K. I., McCann, U. D., & Ricaurte, G. A. (1998). Memory impairment in abstinent MDMA (‘Ecstasy’) users. Neurology, 51, 1532–1537.
   PubMed Web of Science ®Google Scholar
• Butler, G. K. L. & Montgomery, A. M. J. (2004). Impulsivity, risk taking and recreational ‘ecstasy’ (MDMA) use. Drug and Alcohol Dependence, 76, 55–62.
   PubMed Web of Science ®Google Scholar
• Cole, J. C., Sumnall, H. R. & Wagstaff, G. F. (2002). Methodological problems with ecstasy and the SCL-90. Psychopharmacology, 162, 215–217.
   PubMed Web of Science ®Google Scholar
• Derogatis, L. R. (1994). The SCL-90 Scoring Manual. Johns Hopkins School of Medicine, Clinical Psychometrics Unit.
   Google Scholar
• de Win, M. M. L., Schilt, T., Reneman, L., Vervaeke, H., Jager, G., Dijkink, S., Booij, J., & van den Brink, W. (2006). Ecstasy use and self-reported depression, impulsivity and sensation seeking: a prospective cohort study. Journal of Psychopharmacology, 20, 226–235.
   Web of Science ®Google Scholar
• Gamma, A., Frei, E., Lehmann, D., Pascual, R. D., Hell, D., & Vollenweider, F. X. (2000) Mood state and brain electric activity in Ecstasy users. Neuroreport, 11, 157–162.
   PubMed Web of Science ®Google Scholar
• Gerra, G., Zaimovic, A., Giucastro, G., Maestri, D., Monica, C., Sartori, R., (1998). Serotonergic function after 3,4-methylenedioxymethamphetamine (‘Ecstasy’) in humans. International Clinical Psychopharmacology, 13, 1–9.
   PubMed Web of Science ®Google Scholar
• Gerra, G., Zaimovic, A., Ferri, M., Zambelli, U., Timpano, M., (2000). Long-lasting effects of 3,4-methylenedioxymethamphetamine (Ecstasy) on serotonin system function in humans. Biological Psychiatry, 47, 127–136.
   PubMed Web of Science ®Google Scholar
• Green, A. R., Cross, A. J. & Goodwin, G. M. (1995). Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy). Psychopharmacology, 119, 247–260.
   PubMed Web of Science ®Google Scholar
• Gouzoulis-Mayfrank, E., Thimm, B., Rezk, M., Hensen, G. & Daumann, J. (2003). Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users. Progress in Neuropsychopharmacology Biology and Psychiatry, 27, 819–827.
   PubMedGoogle Scholar
• Gouzoulis-Mayfrank, E., & Daumann, J. (2006). The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview. Journal of Psychopharmacology, 20, 188–193.
   PubMed Web of Science ®Google Scholar
• Johnston, L. D., O'Malley, P. M. & Bachman, J. G. (2000). The Monitoring the Future National survey results on adolescent drug use: Overview of the key findings, 1999 (NIH publication No. 00-4690). Rockville: National Institute on Drug Abuse.
   Google Scholar
• Kish, S. J., Furukawa, Y., Ang, L., Vorce, S. P., & Kalasinsky, K. S. (2000). Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user. Neurology, 55, 294–296.
   PubMedGoogle Scholar
• Klugman, A., Hardy, S., Baldewegm, T., & Gruzelier, J. (1999). Toxic effect of MDMA on brain serotonin neurons. Lancet, 353, 1269–1267.
   Google Scholar
• Kokkevi, A., Stefanis, N., Anastasopoulou, E., & Kostogianni, C. (1998). Personality disorders in drug abusers: prevalence and their association with AXIS 1 disorders as predictors of treatment retention. Addictive Behaviour, 23, 841–853.
   PubMed Web of Science ®Google Scholar
• Lamers, C. T. J., Bechara, A., Rizzo, M., & Ramaekers, J. G. (2006). Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls. Journal of Psychopharmacology, 20, 302–311.
   PubMed Web of Science ®Google Scholar
• Lieb, R., Schuetz, C. G., Pfister, H., von Sydow, K., & Wittchen, H. (2002). Mental disorders in ecstasy users: A prospective-longitudinal investigation. Drug and Alcohol Dependence, 68, 195–207.
   PubMed Web of Science ®Google Scholar
• MacInnes, N., Handley, S. L., & Harding, G. F. (2001). Former chronic methylenedioxymeth-amphetamine (MDMA or ecstasy) users report mild depressive symptoms. Journal of Psychopharmacology, 15, 181–186.
   PubMed Web of Science ®Google Scholar
• McCann, U. D., & Ricaurte, G. (1991). Lasting neuropsychiatric sequelae of methylene-dioxymethamphetamine (‘ecstasy’) in recreational users. Journal of Clinical Psychopharmacology, 11, 302–305.
   PubMedGoogle Scholar
• McCann, U. D., Ridenour, A., Shaham, Y., & Ricaurte, G. A. (1994). Serotonin neurotoxicity after 3,4-methylenedioxymethamphetamine (MDMA; ‘ecstasy’): a controlled study in humans. Neuropsychopharmacology, 20, 129–138.
   Google Scholar
• McCann, U. D., Slate, S. O., & Ricaurte, G. A. (1996). Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; ‘ecstasy’). Drug Safety, 15, 107–115.
   PubMed Web of Science ®Google Scholar
• McCann, U. D., Szabo, Z., Scheffelm U., Dannalsm R. F., & Ricaurte, G. A. (1998). Positron emission tomographic evidence of toxic effects of MDMA (‘ecstasy’) on brain serotonin neurones in human beings. Lancet, 352, 1433–1437.
   PubMed Web of Science ®Google Scholar
• Morgan, M.J. (1998a). Recreational use of Ecstasy (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology, 19, 252–264.
   PubMed Web of Science ®Google Scholar
• Morgan, M .J. (1998b). Lasting psychological sequelae of recreational use of MDMA (‘Ecstasy”): Controlled studies in humans. Journal of Psychopharmacology, 12, 101–102.
   Google Scholar
• Morgan, M.J. (1999). Memory deficits associated with recreational use of ‘ecstasy’ (MDMA). Psychopharmacology, 141, 30–36.
   PubMed Web of Science ®Google Scholar
• Morgan, M. J., McFie, L., Fleetwood, L. H., & Robinson, J. A. (2002). ‘Ecstasy’ (MDMA): Are the psychological problems associated with its use reversed by prolonged abstinence? Psychopharmacology, 159, 294–303.
   PubMed Web of Science ®Google Scholar
• Parrott, A. C., Milani, R. M. & Turner, J. J. D. (2002). Ecstasy and the SCL90 findings: a reply to Cole et al. Psychopharmacology, 162, 218–222.
   Google Scholar
• Parrott, A. C., Lees, A., Garnham, N. J., Jones, M, & Wesnes, K. (1998). Cognitive performance in recreational users of MDMA or ‘ecstasy’: evidence for memory deficits. Journal of Psychopharmacology, 12, 79–83.
   PubMed Web of Science ®Google Scholar
• Parrott, A. C., Sisk, E., &Turner, J. J. D. (2000). Psychobiological problems in heavy ‘Ecstasy’ (MDMA) polydrug users. Drug and Alcohol Dependence, 60, 105–110.
   PubMed Web of Science ®Google Scholar
• Reneman, L., Booij, J., Schmand, B., Brink, W., & Gunning, B. (2000). Memory disturbances in ‘Ecstasy’ users are correlated with an altered serotonin neurotransmission. Psychopharmacology, 148, 322–324.
   PubMed Web of Science ®Google Scholar
• Reneman, L., Lavalaye, J., Schmand, B., de Wolff, F. A., van den Brink, W., den Heeten, G. J., & Booij, J. (2001). Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or ‘ecstasy’): Preliminary findings. Archives of General Psychiatry, 58, 901–906.
   PubMed Web of Science ®Google Scholar
• Ricaurte, G. A., Martello, A. L., Katz, J. L., & Martello, M. B. (1992). Lasting effects of 3,4- methylenedioxymethamphetamine (MDMA) on central serotonergic neurones in nonhuman primates: neurochemical observations. Journal of Pharmacology and Experimental Therapeutics, 261, 616–622.
   PubMed Web of Science ®Google Scholar
• Ricaurte, G., Yuan, J., & McCann, U. D. (2000). 3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’)-induced serotonin neurotoxicity: Studies in animals. Neuropsychobiology, 42, 5–10.
   PubMed Web of Science ®Google Scholar
• Rogers, G., Elston, J., Garside, R., Roome, C., Taylor, R., Younger, P., (2009). The harmful health effects of recreational ecstasy: a systematic review of observational evidence. Health & Technology Assessment, 13(6).
   Google Scholar
• Saunders, N. (1995). Ecstasy and the Dance Culture. London: Neal's Yard Desktop Publishing.
   Google Scholar
• Schifano, F., Di Furia, L., Forza, G., Minicuci, N., & Bricolo, R. (1998). MDMA (‘ecstasy’) consumption in the context of polydrug abuse: A report on 150 patients. Drug and Alcohol Dependence, 52, 85–90.
   PubMed Web of Science ®Google Scholar
• Semple, D.M., Ebmeier, K.P., Glabus, M.F., O'Carroll, R.E., & Johnstone, E.C. (1999). Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA (‘ecstasy’) users. British Journal of Psychiatry, 175, 63–69.
   PubMed Web of Science ®Google Scholar
• Solowij, N., Hall, W., & Lee, N. (1992). Recreational MDMA use in Sydney: A profile of ‘Ecstasy’ users and their experiences with the drug. British Journal of Addiction, 87, 1161–1172.
   PubMedGoogle Scholar
• Steele, T.D., McCann, U. D., & Ricaurte, G.A. (1994). 3,4-methylenedioxymethamphetamine (MDMA; ‘ecstasy’): pharmacology and toxicology in animals and humans. Addiction, 89, 539–551.
   PubMed Web of Science ®Google Scholar
• Tasker, T., Raw, M., & McNeill, A. (1999). Drug realities: A summary of the results of the 1996 National Drugs Campaign Survey. London: Health Education Authority.
   Google Scholar
• Thomasius, R., Petersen, K., Buchert, R., Andresen, B., Zapletalova, P., (2003). Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users. Psychopharmacology, 167, 85–96.
   PubMed Web of Science ®Google Scholar
• United Nations (2003). United Nations Office on Drugs and Crime, Ecstasy and Amphetamines: Global Survey 2003. New York: UN Publication Sales No. E.03.XI.15, United Nations Office on Drugs and Crime, United Nations.
   Google Scholar
• Wareing, M., Fisk, J. E., & Murphy, P. N. (2000) Working memory deficits in current and previous users of MDMA (‘ecstasy’). British Journal of Psychology, 91, 181–188.
   PubMed Web of Science ®Google Scholar
• Webb, E., Ashton, C. H., Kelly, P., & Kamali, F. (1996) Alcohol and drug use in UK university students. Lancet, 348, 922–925.
   PubMed Web of Science ®Google Scholar